1. Home
  2. CBLL

as of 09-02-2026 3:45pm EST

$24.74
+$0.16
+0.65%
Stocks Nasdaq

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Founded: 2014 Country:
United States
United States
Employees: N/A City: SUNNYVALE
Market Cap: 726.2M IPO Year: 2024
Target Price: $23.20 AVG Volume (30 days): 359.7K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.03 EPS Growth: 56.93
52 Week Low/High: $10.85 - $25.33 Next Earning Date: 05-11-2026
Revenue: $89,063,000 Revenue Growth: 36.09%
Revenue Growth (this year): 29.57% Revenue Growth (next year): 28.44%
P/E Ratio: -23.86 Index: N/A
Free Cash Flow: -41575000.0 FCF Growth: N/A

AI-Powered CBLL Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 70.15%
70.15%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of CeriBell Inc. (CBLL)

Foehr David

Senior VP, Finance and PAO

Sell
CBLL Aug 24, 2026

Avg Cost/Share

$23.95

Shares

859

Total Value

$20,573.05

Owned After

35,899

SEC Form 4

Chao Xingjuan

President and CEO

Sell
CBLL Aug 21, 2026

Avg Cost/Share

$24.02

Shares

6,068

Total Value

$145,753.36

Owned After

781,731

SEC Form 4

Blumberg Scott

Chief Financial Officer

Sell
CBLL Aug 21, 2026

Avg Cost/Share

$24.02

Shares

1,521

Total Value

$36,534.42

Owned After

146,600

SEC Form 4

Manni Joseph S.

Chief Revenue Officer

Sell
CBLL Aug 21, 2026

Avg Cost/Share

$24.02

Shares

1,361

Total Value

$32,691.22

Owned After

55,956

SEC Form 4

Foehr David

Senior VP, Finance and PAO

Sell
CBLL Aug 21, 2026

Avg Cost/Share

$24.02

Shares

993

Total Value

$23,851.86

Owned After

35,899

SEC Form 4

Woo Raymond

Chief Technology Officer

Sell
CBLL Aug 21, 2026

Avg Cost/Share

$24.02

Shares

1,979

Total Value

$47,535.58

Owned After

194,729

SEC Form 4

Chao Xingjuan

President and CEO

Sell
CBLL Aug 19, 2026

Avg Cost/Share

$25.03

Shares

31,415

Total Value

$786,317.45

Owned After

781,731

SEC Form 4

Blumberg Scott

Chief Financial Officer

Sell
CBLL Aug 19, 2026

Avg Cost/Share

$25.03

Shares

33,512

Total Value

$838,805.36

Owned After

146,600

SEC Form 4

Chao Xingjuan

President and CEO

Sell
CBLL Aug 18, 2026

Avg Cost/Share

$25.00

Shares

2,199

Total Value

$54,975.00

Owned After

781,731

SEC Form 4

Blumberg Scott

Chief Financial Officer

Sell
CBLL Aug 18, 2026

Avg Cost/Share

$25.00

Shares

990

Total Value

$24,750.00

Owned After

146,600

SEC Form 4

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2026
Q2

Q2 2026 Earnings

8-K SELL

Aug 10, 2026 · 100% conf.

AI Prediction SELL

1D

-7.97%

$17.76

Act: +10.41%

5D

-14.07%

$16.58

20D

-10.87%

$17.20

Price: $19.30 Prob +5D: 0% AUC: 1.000
0001193125-26-342463

Transcript text not available. View on SEC.gov →

2026
Q1

Q1 2026 Earnings

8-K

May 11, 2026

0001193125-26-216821

Transcript text not available. View on SEC.gov →

2025
Q4

Q4 2025 Earnings

8-K

Feb 24, 2026

0001193125-26-067136

Transcript text not available. View on SEC.gov →

Share on Social Networks: